Novocure Ltd.
(NASDAQ : NVCR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
-0.33%69.260.8%$490.79m
ISRGIntuitive Surgical, Inc.
-1.44%496.212.4%$488.68m
MDTMedtronic PLC
-0.32%91.780.6%$465.10m
TMOThermo Fisher Scientific Inc.
0.04%235.121.0%$452.18m
ALGNAlign Technology, Inc.
-0.10%219.116.3%$427.81m
BDXBecton, Dickinson and Company
-0.03%234.431.1%$312.96m
EWEdwards Lifesciences Corporation
-0.35%147.721.2%$282.97m
BAXBaxter International Inc.
0.79%63.531.7%$281.45m
BSXBoston Scientific Corporation
-1.35%36.171.1%$279.12m
ABMDABIOMED, Inc.
-5.23%313.363.3%$231.91m
SYKStryker Corporation
-1.26%165.711.3%$230.20m
DXCMDexCom, Inc.
-2.68%138.908.5%$179.17m
ZBHZimmer Biomet Holdings, Inc.
-0.58%112.261.7%$145.05m
WATWaters Corporation
0.08%196.043.4%$141.42m
IDXXIDEXX Laboratories, Inc.
-1.28%196.303.7%$122.48m

Company Profile

Novocure Ltd. operates as an oncology company. It enages in developing its propriety technoclogy, Tumor Treating Fields, which uses electric fields tuned to specific frequencies to disrupt cancer cell division, inhibiting tumor growth, and causing affected cancer cells to die. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.